# One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

> **NCT06236516** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Lung Cancer
- Oligometastatic Lung Tumor

## Interventions

- **RADIATION:** One fraction stereotactic body radiotherapy
- **DEVICE:** HyperSight
- **DEVICE:** Ethos

## Key facts

- **NCT ID:** NCT06236516
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-26
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-08-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06236516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06236516, "One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06236516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*